The prediction of parasuicide repetition in a high-risk group.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 10590825)

Published in Br J Clin Psychol on November 01, 1999

Authors

G L Sidley1, R Calam, A Wells, T Hughes, K Whitaker

Author Affiliations

1: Department of Clinical Psychology, North Manchester General Hospital, UK.

Articles by these authors

(truncated to the top 100)

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias. N Engl J Med (2013) 6.67

Male attractiveness and differential testosterone investment in zebra finch eggs. Science (1999) 5.14

A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry (1988) 4.98

Compulsory psychiatric treatment in the community. I. A controlled study of compulsory community treatment with extended leave under the Mental Health Act: special characteristics of patients treated and impact of treatment. Br J Psychiatry (1991) 4.57

A competency model for general practice: implications for selection, training, and development. Br J Gen Pract (2000) 4.25

Cell adhesion and motility depend on nanoscale RGD clustering. J Cell Sci (2000) 4.13

Compulsory psychiatric treatment in the community. II. A controlled study of patients whom psychiatrists would recommend for compulsory treatment in the community. Br J Psychiatry (1991) 4.09

Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J Cell Biol (2000) 3.63

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib. Leukemia (2008) 3.58

Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis. Arthritis Rheum (2010) 2.37

Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem (2000) 2.37

Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling. J Biol Chem (2001) 2.16

Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol (1994) 2.12

Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol (1998) 2.11

Epidermal growth factor and membrane trafficking. EGF receptor activation of endocytosis requires Rab5a. J Cell Biol (2000) 2.09

Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol Cell Biol (2004) 2.08

A placebo-controlled trial of ketotifen (HC 20-511, Sandoz) in allergen induced asthma and comparison with disodium cromoglycate. Clin Allergy (1979) 1.98

Two psychological treatments for hypochondriasis. A randomised controlled trial. Br J Psychiatry (1998) 1.95

A survey of the demographics of blood use. Transfus Med (2007) 1.95

Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia. Leukemia (2006) 1.95

Beliefs about worry and intrusions: the Meta-Cognitions Questionnaire and its correlates. J Anxiety Disord (1997) 1.76

Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer (2007) 1.75

Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis. J Cell Biol (1994) 1.75

Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J Cell Biol (2001) 1.74

Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax (2009) 1.74

Epidermal growth factor alters fibroblast migration speed and directional persistence reciprocally and in a matrix-dependent manner. J Cell Sci (1998) 1.72

Engineering epidermal growth factor for enhanced mitogenic potency. Nat Biotechnol (1996) 1.68

EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCgamma signaling pathway. J Cell Sci (1998) 1.68

Expressed sequences from conidial, mycelial, and sexual stages of Neurospora crassa. Fungal Genet Biol (1997) 1.62

Biophysical integration of effects of epidermal growth factor and fibronectin on fibroblast migration. Biophys J (1999) 1.58

Genetically encoded fluorescent sensors of membrane potential. Brain Cell Biol (2008) 1.57

Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts. J Biol Chem (1999) 1.57

EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. Clin Exp Metastasis (1996) 1.57

Effect of epidermal growth factor receptor internalization on regulation of the phospholipase C-gamma1 signaling pathway. J Biol Chem (1999) 1.57

The effect of a child's disability on mother's mental health. Arch Dis Child (1996) 1.56

HCF-dependent nuclear import of VP16. EMBO J (1999) 1.56

Ultrasonographic monitoring of limb lengthening. J Bone Joint Surg Br (1992) 1.53

IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity. J Cell Biol (1999) 1.53

A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility. J Cell Biol (1996) 1.45

In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Hum Gene Ther (1996) 1.45

Significance of residual leukaemia transcripts after bone marrow transplant for CML. Lancet (1990) 1.40

An unexpectedly rapid decline in the X-ray afterglow emission of long gamma-ray bursts. Nature (2005) 1.39

Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. Br J Cancer (2007) 1.39

STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J Biol Chem (1996) 1.35

Mitogenic signaling from the egf receptor is attenuated by a phospholipase C-gamma/protein kinase C feedback mechanism. Mol Biol Cell (1996) 1.35

Fatty acid-induced insulin resistance in adipocytes. Endocrinology (1997) 1.35

In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clin Exp Metastasis (1995) 1.32

Tumor invasion as dysregulated cell motility. Semin Cancer Biol (2001) 1.31

"Subclinical" pacemaker syndrome: a randomised study of symptom free patients with ventricular demand (VVI) pacemakers upgraded to dual chamber devices. Br Heart J (1992) 1.30

Polymerase chain reaction for detection of residual leukaemia. Lancet (1989) 1.28

Localization of epidermal growth factor receptor in hepatocyte nuclei. Hepatology (1991) 1.27

Progression-free interval in ovarian cancer and predictive value of an ex vivo chemoresponse assay. Int J Gynecol Cancer (2006) 1.25

A role for phospholipase C-gamma-mediated signaling in tumor cell invasion. Clin Cancer Res (1999) 1.25

Comparison of BD Vacutainer SST Plus Tubes with BD SST II Plus Tubes for common analytes. Clin Chim Acta (2001) 1.22

Brief cognitive therapy for panic disorder: a randomized controlled trial. J Consult Clin Psychol (1999) 1.22

Mathematical modeling of epidermal growth factor receptor signaling through the phospholipase C pathway: mechanistic insights and predictions for molecular interventions. Biotechnol Bioeng (2000) 1.21

Two large virion envelope glycoproteins mediate Epstein-Barr virus binding to receptor-positive cells. J Virol (1982) 1.21

Kinins: possible mediators of neonatal circulatory changes in man. J Clin Invest (1968) 1.19

miRNA and piRNA localization in the male mammalian meiotic nucleus. Chromosome Res (2008) 1.19

A negative feedback loop attenuates EGF-induced morphological changes. J Cell Biol (1991) 1.18

A novel gene conserved from yeast to humans is involved in sterol biosynthesis. J Lipid Res (2001) 1.18

Kinetic and spectroscopic evidence for three actomyosin:ADP states in smooth muscle. J Biol Chem (2000) 1.18

Persistent activation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkappaB family proteins. Hepatology (1999) 1.17

Reactions of police officers to body-handling after a major disaster. A before-and-after comparison. Br J Psychiatry (1991) 1.17

Assault after ingestion of antidepressant. BMJ (1991) 1.15

Phosphatidylinositol-4-phosphate 5-kinase-1beta is essential for epidermal growth factor receptor-mediated endocytosis. J Biol Chem (2001) 1.14

Receptors for the complement C3d component and the Epstein-Barr virus are quantitatively coexpressed on a series of B-cell lines and their derived somatic cell hybrids. Cell Immunol (1982) 1.13

Prevalence of tendinitis and related disorders of the upper extremity in a manufacturing workforce. J Rheumatol (1990) 1.11

Insulin-like and insulin-inhibitory effects of monoclonal antibodies for different epitopes on the human insulin receptor. Biochem J (1987) 1.09

STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell lines. Br J Cancer (2006) 1.08

Uveitis and arthritis induced by systemic injection of streptococcal cell walls. Invest Ophthalmol Vis Sci (1986) 1.08

The sonic hedgehog receptor patched associates with caveolin-1 in cholesterol-rich microdomains of the plasma membrane. J Biol Chem (2001) 1.06

Cannabis, hypochlorhydria, and cholera. Lancet (1978) 1.05

The role of bacterial vaginosis in infection after major gynecologic surgery. Infect Dis Obstet Gynecol (1999) 1.04

Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death. J Immunol (2001) 1.04

Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha. J Cell Physiol (1996) 1.04

Molar intercuspal dimensions: genetic input to phenotypic variation. J Dent Res (2003) 1.03

Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation (1989) 1.03

Ligand-induced internalization and increased cell calcium are mediated via distinct structural elements in the carboxyl terminus of the epidermal growth factor receptor. J Biol Chem (1991) 1.02

EGF receptor signaling in prostate morphogenesis and tumorigenesis. Histol Histopathol (1999) 1.02

Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors. J Biol Chem (2000) 1.02

Epigenetic influences may explain dental differences in monozygotic twin pairs. Aust Dent J (2005) 1.00

The Thought Control Questionnaire--psychometric properties in a clinical sample, and relationships with PTSD and depression. Psychol Med (1999) 1.00

Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline. Br J Cancer (2005) 1.00

Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis Rheum (2000) 1.00

Brain stem stroke causing baroreflex failure and paroxysmal hypertension. Stroke (2000) 1.00

PLC gamma contributes to metastasis of in situ-occurring mammary and prostate tumors. Oncogene (2006) 0.99

Methadone-maintained former heroin addicts, including those who are anti-HIV-1 seropositive, comply with and respond to hepatitis B vaccination. Addiction (1999) 0.99

Psychiatric comorbidity in methadone maintained patients. J Addict Dis (1998) 0.99

An experimental investigation of the role of safety-seeking behaviours in the maintenance of panic disorder with agoraphobia. Behav Res Ther (1999) 0.98

Cognitive factors in predisposition to auditory and visual hallucinations. Br J Clin Psychol (2000) 0.98

Proliferative response of fibroblasts expressing internalization-deficient epidermal growth factor (EGF) receptors is altered via differential EGF depletion effect. Biotechnol Prog (1994) 0.98

Resonance enhancement of two-photon absorption in fluorescent proteins. J Phys Chem B (2007) 0.98

Enhanced tumorigenesis of NR6 cells which express non-down-regulating epidermal growth factor receptors. Cancer Res (1991) 0.97

Speech and language therapy for dysarthria due to non-progressive brain damage. Cochrane Database Syst Rev (2005) 0.96

Gamma-ray bursts: huge explosion in the early Universe. Nature (2006) 0.96

p53 in chronic myeloid leukemia cell lines. Leukemia (1992) 0.95

Microcirculation of the tracheobronchial tree. Nature (1965) 0.95

A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response. Leukemia (2009) 0.93

Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma. J Immunol (1998) 0.93